Clinical Trial Update: Greatest International Antiinfective Trial With Avelox

View source ↗

Summary

A completed international trial evaluating the antiinfective antibiotic moxifloxacin (Avelox) for chronic bronchitis and related bronchial conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Diseases
• Bronchitis

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Bronchitis, Chronic, Bronchial Diseases | Status: COMPLETED